Skip to main content
N4 PHARMA PLC logo

N4 PHARMA PLC — Investor Relations & Filings

Ticker · N4P ISIN · GB00BYW8QM32 LEI · 213800I841D2RKMFK955 IL Professional, scientific and technical activities
Open in API
Filings indexed 840 across all filing types
Latest filing 2020-05-20 Major Shareholding Noti…
Country GB United Kingdom
Listing IL N4P

About N4 PHARMA PLC

https://n4pharma.com/

N4 Pharma PLC is a specialist pharmaceutical company focused on the development of Nuvec®, its proprietary silica nanoparticle delivery system. This platform technology is designed to enhance the cellular delivery and potency of nucleic acid-based treatments, such as vaccines and cancer therapies. The company's primary focus is on applying Nuvec® to enable advanced therapies for oncology and infectious diseases. N4 Pharma's business model involves developing and out-licensing its technology to pharmaceutical and biotechnology partners to improve the performance of new and existing drugs.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is clearly identified as an 'RNS Number' filing from the 'National Storage Mechanism'. The content is structured as a 'TR-1: Standard form for notification of major holdings', which details changes in voting rights due to an acquisition/disposal or an event changing the breakdown of voting rights. This type of mandatory disclosure regarding significant changes in share ownership thresholds falls under the category of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2020-05-20 English
Second Price Monitoring Extn
Interest Rate Update/Notice Classification · 1% confidence The document is very short (1370 characters) and is explicitly labeled as an 'RNS Number'. The content describes a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange, which is a specific operational announcement rather than a comprehensive financial report (like 10-K or IR) or a standard corporate action (like DIV or ER). Since it is a general regulatory announcement provided by RNS and does not fit into the more specific categories (like DIRS, DIV, ER, etc.), the most appropriate classification is the general regulatory filing fallback category.
2020-05-18 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1353 characters) and explicitly states it is an 'RNS Number' notification from the London Stock Exchange regarding a 'Price Monitoring Extension' for a security. It describes a temporary trading mechanism adjustment rather than a comprehensive financial report, management change, or shareholder vote result. Since it is a general regulatory announcement provided via the RNS service and does not fit into the more specific categories like DIV, ER, or 10-K, the most appropriate classification is the general Regulatory Filings category.
2020-05-18 English
Grant of Options
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated May 18, 2020. The content details the 'Grant of Options' over ordinary shares to Directors and includes mandatory FCA notifications regarding transactions by persons discharging managerial responsibilities (PDMRs) under the EU Market Abuse Regulation. This type of announcement, which reports insider transactions (Director's Dealing) and is disseminated via the Regulatory News Service (RNS), fits the definition of Director's Dealing (DIRS). While it is distributed via RNS, the specific subject matter is insider trading notification, making DIRS the most precise classification over the general RNS fallback.
2020-05-18 English
Patent filing update
Environmental & Social Information Classification · 1% confidence The document is very short (2956 characters) and is explicitly marked with an 'RNS Number' and states that the information is provided by 'RNS, the news service of the London Stock Exchange.' The content details an update on a patent filing process, which is a specific corporate event announcement, not a comprehensive financial report (like 10-K or IR) or a presentation (like IP). According to Rule 2, short announcements that convey specific corporate news and are distributed via an official regulatory news service should be classified based on their content or as a general regulatory filing. Since this is a specific update on intellectual property/legal matters but is primarily distributed as a regulatory news service announcement, and it doesn't fit perfectly into LTR (Legal Proceedings Report, which usually implies litigation), the most appropriate general regulatory category for non-standard, timely announcements distributed via RNS is RNS, or potentially LTR if focusing on the patent aspect. Given the strong emphasis on the RNS distribution mechanism and the nature of the update (patent filing progress), RNS is the most fitting general regulatory classification for this type of market communication.
2020-05-18 English
Statement Re: Share Price Movement
Share Issue/Capital Change Classification · 1% confidence The document is identified by the header 'RNS Number : 0864N' and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' RNS filings are general regulatory announcements that do not fit into more specific categories like 10-K, ER, or DIV. The content discusses ongoing discussions regarding funding for a clinical trial, which is a material event requiring immediate disclosure via the regulatory news service. Given the explicit RNS identification and the nature of the announcement (material non-public information disclosure), the most appropriate classification is Regulatory Filings (RNS). The document length is short (2978 chars), but it is the primary announcement itself, not an announcement *about* another report, so RPA is less suitable than RNS for this type of market-sensitive update.
2020-05-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.